Empresa Calmare Therapeutics Incorporated
Acciones
CTTC
US13126R1023
Equipo médico y tecnología avanzada
Resumen de negocios
Número de empleados: 7
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Conrad Mir
CEO | Chief Executive Officer | 55 | 27/09/13 |
Director of Finance/CFO | 71 | - | |
Donna Mays
ADM | Chief Administrative Officer | - | - |
Stephen D'Amato
CTO | Chief Tech/Sci/R&D Officer | - | - |
William Lipford
SAM | Sales & Marketing | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Rustin Howard
BRD | Director/Board Member | 67 | 01/10/07 |
Conrad Mir
CEO | Chief Executive Officer | 55 | 27/09/13 |
Stanley Yarbro
BRD | Director/Board Member | 74 | - |
Peter Brennan
CHM | Chairman | 69 | 06/06/11 |
Santanu Das
BRD | Director/Board Member | - | 12/07/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 38 997 971 | 38 997 971 ( 100,00 %) | 0 | 99,99 % |
Acción B | 0 | 2 427 | 0 | 0 |
Información de la empresa
Calmare Therapeutics, Inc.
2 Trap Falls Road Suite 507
06484, Shelton
+
http://www.calmaretherapeutics.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+12,50 % | 228 mil M | |
+14,52 % | 196 mil M | |
+17,51 % | 141 mil M | |
+28,96 % | 110 mil M | |
+1,10 % | 65,88 mil M | |
+18,16 % | 54,3 mil M | |
+7,63 % | 52,39 mil M | |
+10,95 % | 45,22 mil M | |
+5,10 % | 37,12 mil M |